Through our cell engineering platform, we are developing cell therapies that target disease and drive cutting-edge research in the field.
Using cellular engineering, we have developed a platform to produce female reproductive cell lines. We use proprietary combinations of transcription factors to generate engineered ovarian cell lines that mimic the functions of endogenous cells, producing and responding to all hormones.
Our team of cellular engineers is using this platform to advance a portfolio of cellular therapeutics for female reproductive diseases.
We are working on applications that address women’s health, including assisted fertility outcomes, ovarian disease, menopause, and more.